NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球狂犬病(恐水症)治療市場(2020年∼2024年)

Global Rabies Treatment Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 979865
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
全球狂犬病(恐水症)治療市場(2020年∼2024年) Global Rabies Treatment Market 2020-2024
出版日期: 2020年12月08日內容資訊: 英文 120 Pages
簡介

全球狂犬病(恐水症)治療的市場規模在2020年∼2024年間,預測將成長到10億6000萬美元,在預測期間內預計將以5%的年複合成長率推移。市場成長的主要因素有疫苗的需求,新興經濟各國流浪動物的問題日益嚴重以及新的管理途徑。

本報告提供狂犬病(恐水症)治療市場調查,提供市場概要,市場成長要素及阻礙因素分析,各類型·各地區的市場規模的變化與預測,供應商分析,市場機會等全面性資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模2019
  • 市場預測:從2019年∼2024年的預測
  • 4波特的五力分析
  • 五力總結
  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

各產品的市場區隔

  • 市場區隔
  • 各產品比較
  • 疫苗-市場規模與預測(2019年-2024年)
  • RIG-市場規模與預測(2019年-2024年)
  • 各產品的市場機會

各用途市場市場區隔

  • 暴露前的疫苗接種
  • 暴露後預防

各給藥途徑市場區隔

  • 皮內給藥途徑
  • 肌肉內給藥途徑
  • 口服給藥途徑

客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 亞洲-市場規模與預測(2019年-2024年)
  • 歐洲-市場規模與預測(2019年-2024年)
  • 北美-市場規模與預測(2019年-2024年)
  • 其他地區-市場規模與預測(2019年-2024年)
  • 主要的主要國家
  • 地區的市場機會
  • 市場推動因素
  • 市場課題
  • 市場趨勢

業者情勢

  • 業者情勢
  • 創造性破壞狀況
  • 競爭模式

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Bavarian Nordic AS
  • Bharat Biotech Ltd.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Inc.
  • Grifols SA
  • Kedrion Spa
  • Merck & Co. Inc.
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • Zoetis Inc.

附錄

目錄
Product Code: IRTNTR45572

Technavio has been monitoring the rabies treatment market and it is poised to grow by $ 1.06 bn during 2020-2024, progressing at a CAGR of 5% during the forecast period. Our report on rabies treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the need for contamination-free vaccines with novel culture media, the growing issue of stray animals in developing economies and novel routes of administration. In addition, the need for contamination-free vaccines with novel culture media is anticipated to boost the growth of the market as well.

The rabies treatment market analysis includes product segment, application segment, route of administration segment and geographical landscapes.

Technavio's rabies treatment market is segmented as below:

By Product

  • Vaccines
  • RIG

By Application

  • Pre-exposure vaccination
  • Post-exposure prophylaxis

By Route of Administration

  • Intradermal route of administration
  • Intramuscular route of administration
  • Oral route of administration

By Geographical Landscapes

  • Asia
  • Europe
  • North America
  • ROW

This study identifies the growing awareness about animal health and welfare as one of the prime reasons driving the rabies treatment market growth during the next few years. Also, the zero human rabies by 2030 initiative and the introduction of monoclonal antibodies will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the rabies treatment market covers the following areas:

  • Rabies treatment market sizing
  • Rabies treatment market forecast
  • Rabies treatment market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading rabies treatment market vendors that include Bavarian Nordic AS, Bharat Biotech Ltd., Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., Grifols SA, Kedrion Spa, Merck & Co. Inc., Sanofi, Serum Institute of India Pvt. Ltd., and Zoetis Inc. Also, the rabies treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
  • 4 Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Vaccines - Market size and forecast 2019-2024
  • RIG - Market size and forecast 2019-2024
  • Market opportunity by Product

Market Segmentation by Application

  • Pre-exposure vaccination
  • Post-exposure prophylaxis

Market Segmentation by Route of Administration

  • Intradermal route of administration
  • Intramuscular route of administration
  • Oral route of administration

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • Asia - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • North America - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Bavarian Nordic AS
  • Bharat Biotech Ltd.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Inc.
  • Grifols SA
  • Kedrion Spa
  • Merck & Co. Inc.
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • Zoetis Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Product - Market share 2019-2024 (%)
  • 22: Comparison by Product
  • 23: Vaccines - Market size and forecast 2019-2024 ($ million)
  • 24: Vaccines - Year-over-year growth 2019-2024 (%)
  • 25: RIG - Market size and forecast 2019-2024 ($ million)
  • 26: RIG - Year-over-year growth 2019-2024 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share by geography 2019-2024 (%)
  • 30: Geographic comparison
  • 31: Asia - Market size and forecast 2019-2024 ($ million)
  • 32: Asia - Year-over-year growth 2019-2024 (%)
  • 33: Europe - Market size and forecast 2019-2024 ($ million)
  • 34: Europe - Year-over-year growth 2019-2024 (%)
  • 35: North America - Market size and forecast 2019-2024 ($ million)
  • 36: North America - Year-over-year growth 2019-2024 (%)
  • 37: ROW - Market size and forecast 2019-2024 ($ million)
  • 38: ROW - Year-over-year growth 2019-2024 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Bavarian Nordic AS - Overview
  • 48: Bavarian Nordic AS - Business segments
  • 49: Bavarian Nordic AS - Key offerings
  • 50: Bavarian Nordic AS - Key customers
  • 51: Bavarian Nordic AS - Segment focus
  • 52: Bharat Biotech Ltd. - Overview
  • 53: Bharat Biotech Ltd. - Product and service
  • 54: Bharat Biotech Ltd. - Key offerings
  • 55: Bharat Biotech Ltd. - Key customers
  • 56: Bharat Biotech Ltd. - Segment focus
  • 57: Boehringer Ingelheim International GmbH - Overview
  • 58: Boehringer Ingelheim International GmbH - Business segments
  • 59: Boehringer Ingelheim International GmbH - Key offerings
  • 60: Boehringer Ingelheim International GmbH - Key customers
  • 61: Boehringer Ingelheim International GmbH - Segment focus
  • 62: Elanco Animal Health Inc. - Overview
  • 63: Elanco Animal Health Inc. - Product and service
  • 64: Elanco Animal Health Inc. - Key offerings
  • 65: Elanco Animal Health Inc. - Key customers
  • 66: Elanco Animal Health Inc. - Segment focus
  • 67: Grifols SA - Overview
  • 68: Grifols SA - Business segments
  • 69: Grifols SA - Key offerings
  • 70: Grifols SA - Key customers
  • 71: Grifols SA - Segment focus
  • 72: Kedrion Spa - Overview
  • 73: Kedrion Spa - Product and service
  • 74: Kedrion Spa - Key offerings
  • 75: Kedrion Spa - Key customers
  • 76: Kedrion Spa - Segment focus
  • 77: Merck & Co. Inc. - Overview
  • 78: Merck & Co. Inc. - Business segments
  • 79: Merck & Co. Inc. - Key offerings
  • 80: Merck & Co. Inc. - Key customers
  • 81: Merck & Co. Inc. - Segment focus
  • 82: Sanofi - Overview
  • 83: Sanofi - Business segments
  • 84: Sanofi - Key offerings
  • 85: Sanofi - Key customers
  • 86: Sanofi - Segment focus
  • 87: Serum Institute of India Pvt. Ltd. - Overview
  • 88: Serum Institute of India Pvt. Ltd. - Product and service
  • 89: Serum Institute of India Pvt. Ltd. - Key offerings
  • 90: Serum Institute of India Pvt. Ltd. - Key customers
  • 91: Serum Institute of India Pvt. Ltd. - Segment focus
  • 92: Zoetis Inc. - Overview
  • 93: Zoetis Inc. - Business segments
  • 94: Zoetis Inc. - Key offerings
  • 95: Zoetis Inc. - Key customers
  • 96: Zoetis Inc. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations